Subscribe To
Qsam biosciences and rls announce clinical and commercial supply agreement for promising clinical-stage metastatic and primary bone cancer treatment, cyclosam®
Partnership is Latest in Series of RLS Efforts to Expand Industry-Leading CDMO Business and Clinical Trial Capability with Radiopharmaceutical Partner...
May 16, 2023, 12:30 pm
Fusion pharmaceuticals to present at the guggenheim healthcare talks radiopharmaceuticals day
HAMILTON, ON and BOSTON , May 9, 2023 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on develo...
May 9, 2023, 7:45 am
Alpha tau medical to present at guggenheim radiopharmaceuticals day
JERUSALEM, May 03, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the inn...
May 3, 2023, 4:00 pm
radiopharmaceuticals market predicted to garner $10.3 bn by 2032; at a cagr of 8.85% | market.us report
The rising popularity of diagnostic and therapeutic nuclear medicines in the radiopharmaceutical market can be attributed to increased consumer awaren...
April 19, 2023, 8:32 pm
Fusion pharmaceuticals to present at the 43rd annual cowen healthcare conference
HAMILTON, ON and BOSTON , March 2, 2023 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on devel...
March 2, 2023, 4:35 pm
Fusion pharmaceuticals to present at the svb securities global biopharma conference
HAMILTON, ON and BOSTON , Feb. 13, 2023 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on devel...
February 13, 2023, 8:05 am
Isoray inc. and viewpoint molecular targeting inc. announce name change to perspective therapeutics inc.
Company’s focus is on the advancement of cancer treatments using radiation, radiopharmaceuticals, and...
February 7, 2023, 10:48 pm
Telix to present at jefferies london healthcare conference 2022
MELBOURNE, Australia, Nov. 11, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company), a commercial-stage biopharmaceutic...
November 11, 2022, 7:00 am
Eli lilly and company (lly) management presents at goldman sachs 43rd annual global healthcare conference (transcript)
Eli Lilly and Company (NYSE:LLY ) Goldman Sachs 43rd Annual Global Healthcare Conference June 14, 2022 1:40 PM ET Company Participants Anne White - SV...
June 14, 2022, 4:16 pm
Point biopharma to participate in upcoming investor conferences
INDIANAPOLIS, May 19, 2022 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating th...
May 19, 2022, 5:30 pm
Fusion pharmaceuticals to present at the guggenheim securities radiopharmaceuticals day
HAMILTON, ON and BOSTON, May 11, 2022 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on devel...
May 11, 2022, 4:45 pm
Point biopharma to participate in upcoming virtual investor conferences
INDIANAPOLIS, Feb. 17, 2022 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating t...
February 17, 2022, 8:30 am
Point biopharma to participate in upcoming virtual investor conferences
INDIANAPOLIS, Feb. 17, 2022 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating t...
February 17, 2022, 8:30 am
Point biopharma to participate in upcoming virtual investor conferences
INDIANAPOLIS, Feb. 17, 2022 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating t...
February 17, 2022, 8:30 am